Prevalence of GBV-C and hepatitis G virus variants in patients with fulminant hepatic failure in Japan (Q42986451)

12 November 2017

Prevalence of GBV-C and hepatitis G virus variants in patients with fulminant hepatic failure in Japan (English)

1 reference

12 November 2017

Tanaka M

1

1 reference

12 November 2017

Nishiguchi S

2

1 reference

12 November 2017

Tanaka T

3

1 reference

12 November 2017

Enomoto M

4

1 reference

12 November 2017

Fukuda K

5

1 reference

12 November 2017

Takeda T

6

1 reference

12 November 2017

Nakajima S

7

1 reference

12 November 2017

Shiomi S

8

1 reference

12 November 2017

Kuroki T

9

1 reference

12 November 2017

Monna T

10

1 reference

12 November 2017

Yano Y

11

1 reference

12 November 2017

Otani S

12

1 reference

12 November 2017

1 December 1997

1 reference

12 November 2017

Journal of Hepatology

1 reference

12 November 2017

27

1 reference

12 November 2017

6

1 reference

12 November 2017

966-972

1 reference

Fulminant and subfulminant liver failure: definitions and causes

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Acute liver failure: redefining the syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Hepatitis C Virus in Fulminant Hepatic Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Exclusion in liver by polymerase chain reaction of hepatitis B and C viruses in acute liver failure attributed to sporadic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Identification of two flavivirus-like genomes in the GB hepatitis agent

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Molecular and serologic analysis in the transmission of the GB hepatitis agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Isolation of novel virus-like sequences associated with human hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

The new GB hepatitis viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Detection of Hepatitis C Virus Antibody in the Absence of Viral RNA in Patients with Autoimmune Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Association between fulminant hepatic failure and a strain of GBV virus C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

GBV-C in the aetiology of fulminant hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Does GBV-C cause fulminant hepatitis in Japan?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Infection with hepatitis GB virus C in patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

The cloning and clinical implications of HGV and HGBV-C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980138-9

7 January 2021

10.1016/S0168-8278(97)80138-9

Identifiers

DOI

1 reference

12 November 2017

1 reference